ESC 365 - scRNA-derived immunesignatures in atherosclerosis as mediators and markers of risk

ESC Professional Premium Access

scRNA-derived immunesignatures in atherosclerosis as mediators and markers of risk

Session: Vascular immunometabolism: emerging mechanisms and therapeutic opportunities

Topic: Leukocytes, Inflammation, Immunity

Speaker: Professor A. Zirlik (Graz, AT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Andreas Zirlik

Medical University of Graz, Graz (Austria)

2 presentations

1 follower

4 more presentations in this session

Immunometabolism

Speaker: Professor G. Norata (Milan, IT)

The metabolic regulation of macrophages and cardiometabolic disease

Speaker: Doctor L. Yvan-Charvet (Nice Cedex 3, FR)

Lipoproteins and immunometabolic reprogramming in atherosclerosis

Speaker: Professor P. Evans (London, GB)

Vascular immunometabolism: emerging mechanisms and therapeutic opportunities - discussion

Access the full session

Vascular immunometabolism: emerging mechanisms and therapeutic opportunities

Speakers: Professor A. Zirlik, Professor G. Norata, Doctor L. Yvan-Charvet, Professor P. Evans

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources